Clinical Trial Update: Achieving Portal Access With Scorpion Post-Approval Study (APASS) [NA]

View source ↗

Summary

Post-approval study APASS evaluating the Scorpion device for portal access in patients with portal hypertension and liver disease was terminated; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Hepatic Hydrothorax
• Liver Disease
• Portal Hypertension
• Vascular Disease

Snippet

Sponsor: Argon Medical Devices | Conditions: Portal Hypertension, Liver Diseases | NA | Status: TERMINATED | Results posted: 2024-12-11